Inhibitors of fatty acid synthesis induce PPAR α -regulated fatty acid β -oxidative genes: Synergistic roles of L-FABP and glucose

PPAR Research

Volumn , Issue , 2013, Pages

  Huang, Huan ^a   McIntosh, Avery L ^a   Martin, Gregory G ^a   Petrescu, Anca D ^a   Landrock, Kerstin K ^a   Landrock, Danilo ^b   Kier, Ann B ^b   Schroeder, Friedhelm ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE INHIBITOR; BINDING PROTEIN; ENZYME INHIBITOR; FATTY ACID; FATTY ACID SYNTHASE INHIBITOR; GLUCOSE; LIVER FATTY ACID BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL NUCLEUS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GENETIC TRANSCRIPTION; INTRACELLULAR SPACE; LIPID STORAGE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

EID: 84875671236     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2013/865604     Document Type: Article

References (114)

1. Landree L. E., Hanlon A. L., Strong D. W., Rumbaugh G., Miller I. M., Thupari J. N., Connolly E. C., Huganir R. L., Richardson C., Witters L. A., Kuhajda F. P., Ronnett G. V., C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism. The Journal of Biological Chemistry 2004 279 5 3817 3827 2-s2.0-9144219529 10.1074/jbc.M310991200 (Pubitemid 38140627)
2. Loftus T. M., Jaworsky D. E., Frehywot C. L., Townsend C. A., Ronnett G. V., Daniel Lane M., Kuhajda F. P., Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 2000 288 5475 2379 2381 2-s2.0-0034733730 10.1126/science.288.5475.2379 (Pubitemid 30448165)
3. Tu Y., Thupari J. N., Kim E.-K., Pinn M. L., Moran T. H., Ronnett G. V., Kuhajda F. P., C75 alters central and peripheral gene expression to reduce food intake and increase energy expenditure. Endocrinology 2005 146 1 486 493 2-s2.0-11144228934 10.1210/en.2004-0976 (Pubitemid 40051775)
4. Anderson N., Borlak J., Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacological Reviews 2008 60 3 311 357 2-s2.0-54049150442 10.1124/pr.108.00001
5. Kneeman J. M., Misdraji J., Corey K. C., Secondary causes of nonalcoholic liver disease. Therapeutic Advances in Gastroenterology 2012 5 3 199 207
6. Nagle C. A., Klett E. L., Coleman R. A., Hepatic triacylglycerol accumulation and insulin resistance. Journal of Lipid Research 2009 50 S74 S79 2-s2.0-66349088529 10.1194/jlr.R800053-JLR200
7. Tiniakos D. G., Vos M. B., Brunt E. M., Nonalcoholic fatty liver disease: pathology and pathogenesis. Annual Review of Pathology 2010 5 145 171 2-s2.0-77649337140 10.1146/annurev-pathol-121808-102132
8. Jin Y.-J., Li S.-Z., Zhao Z.-S., An J. J., Kim R. Y., Kim Y. M., Baik J. H., Lim S. K., Carnitine palmitoyltransferase-1 (CPT-1) activity stimulation by cerulenin via sympathetic nervous system activation overrides cerulenin's peripheral effect. Endocrinology 2004 145 7 3197 3204 2-s2.0-3042687459 10.1210/en.2004-0039 (Pubitemid 38829991)
9. Lopez M., Dieguez C., C75, a fatty acid synthase (FAS) inhibitor. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2007 1 1 53 62
10. McCune S. A., Harris R. A., Mechanism responsible for 5-(tetradecyloxy)-2-furoic acid inhibition of hepatic lipogenesis. The Journal of Biological Chemistry 1979 254 20 10095 10101 2-s2.0-0018605657 (Pubitemid 10162030)
11. Pizer E. S., Thupari J., Han W. F., Pinn M. L., Chrest F. J., Frehywot G. L., Townsend C. A., Kuhajda F. P., Malonyl-CoA is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Research 2000 60 2 213 218 2-s2.0-0034650757 (Pubitemid 30070736)
12. Otto D. A., Chatzidakis C., Kasziba E., Cook G. A., Reciprocal effects of 5-(tetradecyloxy)-2-furoic acid on fatty acid oxidation. Archives of Biochemistry and Biophysics 1985 242 1 23 31 2-s2.0-0022351343 (Pubitemid 16224074)
13. Thupari J. N., Landree L. E., Ronnett G. V., Kuhajda F. P., C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America 2002 99 14 9498 9502 2-s2.0-0037047112 10.1073/pnas.132128899 (Pubitemid 34764642)
14. McCune S. A., Nomura T., Harris R. A., Inhibition of hepatic lipogenesis by 2-tetradecylglycidic acid. Lipids 1979 14 10 880 882 2-s2.0-0018566825 (Pubitemid 10198400)
15. Hubbell T., Behnke W. D., Woodford J. K., Schroeder F., Recombinant liver fatty acid binding protein interacts with fatty Acyl-Coenzyme A. Biochemistry 1994 33 11 3327 3334 2-s2.0-0028293431 (Pubitemid 24112646)
16. Hostetler H. A., McIntosh A. L., Petrescu A. D., Huang H., Atshaves B. P., Murphy E. J., Kier A. B., Schroeder F., Murphy E. J., Rosenberger T. A., Fluorescence methods to assess the impact of lipid binding proteins on ligand activated gene expression. Methods in Lipid-Mediated Signaling 2010 Boca Raton, Fla, USA CRC Press 299 348 Methods in Signal Transduction
17. Schroeder F., Petrescu A. D., Huang H., Atshaves B. P., McIntosh A. L., Martin G. G., Hostetler H. A., Vespa A., Landrock D., Landrock K. K., Payne H. R., Kier A. B., Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids 2008 43 1 1 17 2-s2.0-38849165990 10.1007/s11745-007-3111-z (Pubitemid 351206956)
18. Wolfrum C., Borrmann C. M., Borchers T., Spener F., Fatty acids and hypolipidemic drugs regulate PPARalpha and PPARgamma gene expresion via L-FABP: a signaling path to the nucleus. Proceedings of the National Academy of Sciences 2001 98 2323 2328
19. Hostetler H. A., Kier A. B., Schroeder F., Very-long-chain and branched-chain fatty Acyl-CoAs are high affinity ligands for the peroxisome proliferator-activated receptor α (PPAR α). Biochemistry 2006 45 24 7669 7681 2-s2.0-33745148616 10.1021/bi060198l (Pubitemid 43894957)
20. Hostetler H. A., Petrescu A. D., Kier A. B., Schroeder F., Peroxisome proliferator-activated receptor α (PPAR α) interacts with high affinity and is conformationally responsive to endogenous ligands. The Journal of Biological Chemistry 2005 280 19 18667 18682 2-s2.0-21444456038 10.1074/jbc.M412062200 (Pubitemid 41379567)
21. Jossic-Corcos C. L., Duclos S., Ramirez L. C., Zaghini I., Chevillard G., Martin P., Pineau T., Bournot P., Effects of peroxisome proliferator-activated receptor α activation on pathways contributing to cholesterol homeostasis in rat hepatocytes. Biochimica et Biophysica Acta 2004 1683 1-3 49 58 2-s2.0-3042519202 10.1016/j.bbalip.2004.04.004 (Pubitemid 38844659)
22. Landrier J.-F., Thomas C., Grober J., Duez H., Percevault F., Souidi M., Linard C., Staels B., Besnard P., Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor- α -dependent. The Journal of Biological Chemistry 2004 279 44 45512 45518 2-s2.0-8544237037 10.1074/jbc.M407461200 (Pubitemid 39491537)
23. Lefebvre P., Chinetti G., Fruchart J.-C., Staels B., Sorting out the roles of PPAR α in energy metabolism and vascular homeostasis. Journal of Clinical Investigation 2006 116 3 571 580 2-s2.0-33644652183 10.1172/JCI27989 (Pubitemid 43326861)
24. Lin Q., Ruuska S. E., Shaw N. S., Dong D., Noy N., Ligand selectivity of the peroxisome proliferator-activated receptor α Biochemistry 1999 38 1 185 190 2-s2.0-0033524415 10.1021/bi9816094 (Pubitemid 29035685)
25. Paumelle R., Staels B., Cross-talk between statins and PPAR α in cardiovascular diseases: clinical evidence and basic mechanisms. Trends in Cardiovascular Medicine 2008 18 3 73 78 2-s2.0-43049118952 10.1016/j.tcm.2008. 01.001 (Pubitemid 351626602)
26. Wolfrum C., Cytoplasmic fatty acid binding protein sensing fatty acids for peroxisome proliferator activated receptor activation. Cellular and Molecular Life Sciences 2007 64 19-20 2465 2476 2-s2.0-35648987134 10.1007/s00018-007-7279-4 (Pubitemid 350035620)
27. Desvergne B., Michalik L., Wahli W., Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Molecular Endocrinology 2004 18 6 1321 1332 2-s2.0-2542454565 10.1210/me.2004-0088 (Pubitemid 38692172)
28. Feige J. N., Gelman L., Michalik L., Desvergne B., Wahli W., From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Progress in Lipid Research 2006 45 2 120 159 2-s2.0-32644460092 10.1016/j.plipres.2005.12.002 (Pubitemid 43248732)
29. Kersten S., Desvergne B., Wahli W., Roles of PPARS in health and disease. Nature 2000 405 6785 421 424 2-s2.0-0034713444 10.1038/35013000 (Pubitemid 30367411)
30. Chuang S., Velkov T., Horne J., Porter C. J. H., Scanlon M. J., Characterization of the drug binding specificity of rat liver fatty acid binding protein. Journal of Medicinal Chemistry 2008 51 13 3755 3764 2-s2.0-46849121138 10.1021/jm701192w (Pubitemid 351956507)
31. Chuang S., Velkov T., Horne J., Wielens J., Chalmers D. K., Porter C. J. H., Scanlon M. J., Probing the fibrate binding specificity of rat liver fatty acid binding protein. Journal of Medicinal Chemistry 2009 52 17 5344 5355 2-s2.0-69949089937 10.1021/jm801349e
32. Paulussen R. J. A., Veerkamp J. H., Hilderson H. J., Intracellular fatty acid-binding proteins characteristics and function. Subcellular Biochemistry 1990 16 New York, NY, USA Plenum Press 175 226
33. Velkov T., Interactions between human liver fatty acid binding protein and peroxisome proliferator activated receptor drugs. PPAR Research. In press
34. Martin G. G., Atshaves B. P., Huang H., McIntosh A. L., Williams B. J., Pai P. J., Russell D. H., Kier A. B., Schroeder F., Hepatic phenotype of liver fatty acid binding protein (L-FABP) gene-ablated mice. American Journal of Physiology 2009 297 6 G1053 G1065 2-s2.0-72749092398 10.1152/ajpgi.00116.2009
35. Martin G. G., Hostetler H. A., McIntosh A. L., Tichy S. E., Williams B. J., Russell D. H., Berg J. M., Spencer T. A., Ball J. A., Kier A. B., Schroeder F., Structure and function of the sterol carrier protein-2 (SCP-2) N-terminal pre-sequence. Biochemistry 2008 47 22 5915 5934 (Pubitemid 351770022)
36. Martin G. G., Danneberg H., Kumar L. S., Atshaves B. P., Erol E., Bader M., Schroeder F., Binas B., Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein (L-FABP) gene. The Journal of Biological Chemistry 2003 278 24 21429 21438 2-s2.0-0038498152 10.1074/jbc.M300287200 (Pubitemid 36792539)
37. Martin G. G., Huang H., Atshaves B. P., Binas B., Schroeder F., Ablation of the liver fatty acid binding protein gene decreases fatty acyl CoA binding capacity and alters fatty acyl CoA pool distribution in mouse liver. Biochemistry 2003 42 39 11520 11532 2-s2.0-0141594833 10.1021/bi0346749 (Pubitemid 37205747)
38. Petrescu A. D., Huang H., Hostetler H. A., Schroeder F., Kier A. B., Structural and functional characterization of a new recombinant histidine-tagged acyl CoA a binding protein (ACBP) from mouse. Protein Expression and Purification 2008 58 2 184 193 2-s2.0-39649119844 10.1016/j.pep.2007.11.010
39. Bentebibel A., Sebastián D., Herrero L., López-Viñas E., Serra D., Asins G., Gómez-Puertas P., Hegardt F. G., Novel effect of C75 on carnitine palmitoyltransferase I activity and palmitate oxidation. Biochemistry 2006 45 14 4339 4350 2-s2.0-33645655060 10.1021/bi052186q
40. Mera P., Bentebibel A., López-Viñas E., Cordente A. G., Gurunathan C., Sebastián D., Vázquez I., Herrero L., Ariza X., Gómez-Puertas P., Asins G., Serra D., García J., Hegardt F. G., C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase 1 and decreases food intake and body weight. Biochemical Pharmacology 2009 77 6 1084 1095 2-s2.0-60949111125 10.1016/j.bcp.2008.11.020
41. Kawaguchi A., Yoshlmura T., Okuda S., A new method for the preparation of acyl-CoA thioesters. Journal of Biochemistry 1981 89 2 337 339 2-s2.0-0019533194
42. 13C NMR investigation of cholesterol and fatty acid binding sites. The Journal of Biological Chemistry 1999 274 50 35425 35433 2-s2.0-0033544895 10.1074/jbc.274.50.35425 (Pubitemid 129512833)
43. Atshaves B. P., McIntosh A. M., Lyuksyutova O. I., Zipfel W. R., Webb W. W., Schroeder F., Liver fatty acid-binding protein gene ablation inhibits branched-chain fatty acid metabolism in cultured primary hepatocytes. The Journal of Biological Chemistry 2004 279 30 30954 30965 2-s2.0-3843053654 10.1074/jbc.M313571200 (Pubitemid 39037754)
44. McIntosh A. L., Atshaves B. P., Hostetler H. A., Huang H., Davis J., Lyuksyutova O. I., Landrock D., Kier A. B., Schroeder F., Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor- α activity in cultured primary hepatocytes. Archives of Biochemistry and Biophysics 2009 485 2 160 173 2-s2.0-67349154078 10.1016/j.abb.2009.03.004
45. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
46. Zhang J.-Z., Gao L., Widness M., Xi X., Kern T. S., Captopril inhibits glucose accumulation in retinal cells in diabetes. Investigative Ophthalmology and Visual Science 2003 44 9 4001 4005 2-s2.0-0042361953 10.1167/iovs.02-1193 (Pubitemid 37047975)
47. Pieri C., Giuli C., del Moro M., Piantanelli L., Electron-microscopic morphometric analysis of mouse liver. II. Effect of ageing and thymus transplantation in old animals. Mechanisms of Ageing and Development 1980 13 3 275 283 2-s2.0-0019302458 10.1016/0047-6374(80)90040-8 (Pubitemid 10027387)
48. Gallegos A. M., Atshaves B. P., Storey S. M., Starodub O., Petrescu A. D., Huang H., McIntosh A. L., Martin G. G., Chao H., Kier A. B., Schroeder F., Gene structure, intracellular localization, and functional roles of sterol carrier protein-2. Progress in Lipid Research 2001 40 6 498 563 2-s2.0-0034808840 10.1016/S0163-7827(01)00015-7 (Pubitemid 32929969)
49. Hostetler H. A., McIntosh A. L., Atshaves B. P., Storey S. M., Payne H. R., Kier A. B., Schroeder F., Liver type Fatty Acid Binding Protein L-FABP directly interacts with PPAR α in cultured primary hepatocytes. Journal of Lipid Research 2009 50 8 1663 1675 2-s2.0-69449106150 10.1194/jlr.M900058- JLR200
50. Keller G. A., Scallen T. J., Clarke D., Maher P. A., Krisans S. K., Singer S. J., Subcellular localization of sterol carrier protein-2 in rat hepatocytes: its primary localization to peroxisomes. Journal of Cell Biology 1989 108 4 1353 1361 2-s2.0-0024596796 (Pubitemid 19097043)
51. Desvergne B., Wahli W., Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews 1999 20 5 649 688 2-s2.0-0033305213 (Pubitemid 30650602)
52. Robyr D., Wolffe A. P., Wahli W., Nuclear hormone receptor coregulators in action: diversity for shared tasks. Molecular Endocrinology 2000 14 3 329 347 2-s2.0-0034454583 10.1210/me.14.3.329 (Pubitemid 32266074)
53. Savage D. B., Semple R. K., Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance. Current Opinion in Lipidology 2010 21 4 329 336
54. Storey S. M., Atshaves B. P., McIntosh A. L., Landrock K. K., Martin G. G., Huang H., Payne H. R., Johnson J. D., Macfarlane R. D., Kier A. B., Schroeder F., Effect of sterol carrier protein-2 gene ablation on HDL-mediated cholesterol efflux from cultured primary mouse hepatocytes. American Journal of Physiology 2010 299 1 G244 G254 2-s2.0-77954356635 10.1152/ajpgi.00446.2009
55. Storey S. M., McIntosh A. L., Huang H., Martin G. G., Landrock K. K., Landrock D., Payne H. R., Kier A. B., Schroeder F., Loss of intracellular lipid binding proteins differentially impacts saturated fatty acid uptake and nuclear targeting in mouse hepatocytes. American Journal of Physiology 2012 303 7 G837 G850
56. Storey S. M., McIntosh A. L., Huang H., Intracellular cholesterol binding proteins enhance HDL-mediated cholesterol uptake in cultured primary mouse hepatocytes. American Journal of Physiology 2012 302 8 G824 G839 10.1152/ajpgi.00195.2011
57. Fehr M., Lalonde S., Ehrhardt D. W., Frommer W. B., Live imaging of glucose homeostasis in nuclei of COS-7 cells. Journal of Fluorescence 2004 14 5 603 609 2-s2.0-2442603690 10.1023/B:JOFL.0000039347.94943.99
58. Rioux V., Catheline D., Legrand P., In rat hepatocytes, myristic acid occurs through lipogenesis, palmitic acid shortening and lauric acid elongation. Animal 2007 1 6 820 826 2-s2.0-34447632020 10.1017/S1751731107000122 (Pubitemid 47093113)
59. Forman B. M., Chen J., Evans R. M., Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ Proceedings of the National Academy of Sciences of the United States of America 1997 94 9 4312 4317 2-s2.0-0030952937 10.1073/pnas.94.9.4312 (Pubitemid 27194238)
60. Gottlicher M., Widmark E., Li Q., Gustafsson J. A., Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proceedings of the National Academy of Sciences of the United States of America 1992 89 10 4653 4657 2-s2.0-0026551309 10.1073/pnas.89.10.4653
61. Issemann I., Prince R. A., Tugwood J. D., Green S., The peroxisome proliferator-activated receptor: retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. Journal of Molecular Endocrinology 1993 11 1 37 47 2-s2.0-0027525576 (Pubitemid 23297949)
62. Keller H., Dreyer C., Medin J., Mahfoudi A., Ozato K., Wahli W., Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proceedings of the National Academy of Sciences of the United States of America 1993 90 6 2160 2164 2-s2.0-0027447461 (Pubitemid 23078585)
63. Kliewer S. A., Sundseth S. S., Jones S. A., Brown P. J., Wisely G. B., Koble C. S., Devchand P., Wahli W., Willson T. M., Lenhard J. M., Lehmann J. M., Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Proceedings of the National Academy of Sciences of the United States of America 1997 94 9 4318 4323 2-s2.0-0006132932 10.1073/pnas.94.9.4318 (Pubitemid 27194239)
64. Ren B., Thelen A. P., Peters J. M., Gonzalez F. J., Jump D. B., Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor α The Journal of Biological Chemistry 1997 272 43 26827 26832 2-s2.0-0030783119 10.1074/jbc.272.43.26827 (Pubitemid 27452629)
65. Chakravarthy M. V., Pan Z., Zhu Y., Tordjman K., Schneider J. G., Coleman T., Turk J., Semenkovich C. F., 'New' hepatic fat activates PPAR α to maintain glucose, lipid, and cholesterol homeostasis. Cell Metabolism 2005 1 5 309 322 2-s2.0-22544480378 10.1016/j.cmet.2005.04.002 (Pubitemid 43977168)
66. McIntosh A. L., Huang H., Atshaves B. P., Wellberg E., Kuklev D. V., Smith W. L., Kier A. B., Schroeder F., Fluorescent n-3 and n-6 very long chain polyunsaturated fatty acids: three-photon imaging in living cells expressing liver fatty acid-binding protein. The Journal of Biological Chemistry 2010 285 24 18693 18708 2-s2.0-77953315148 10.1074/jbc.M109.079897
67. Norrisa A. W., Spector A. A., Very long chain n-3 and n-6 polyunsaturated fatty acids bind strongly to liver fatty acid-binding protein. Journal of Lipid Research 2002 43 4 646 653 2-s2.0-0036193975 (Pubitemid 34252340)
68. Richieri G. V., Ogata R. T., Kleinfeld A. M., Equilibrium constants for the binding of fatty acids with fatty acid binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. The Journal of Biological Chemistry 1994 269 39 23918 23930 2-s2.0-0028076831
69. Wolfrum C., Börchers T., Sacchettini J. C., Spener F., Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver. Biochemistry 2000 39 6 1469 1474 2-s2.0-0039250873 10.1021/bi991638u (Pubitemid 30090717)
70. di Pietro S. M., Santomé J. A., Isolation, characterization and binding properties of two rat liver fatty acid-binding protein isoforms. Biochimica et Biophysica Acta 2000 1478 2 186 200 2-s2.0-0034705067 10.1016/S0167-4838(00)00042-X (Pubitemid 30312876)
71. Ek B. A., Cistola D. P., Hamilton J. A., Kaduce T. L., Spector A. A., Fatty acid binding proteins reduce 15-lipoxygenase-induced oxygenation of linoleic acid and arachidonic acid. Biochimica et Biophysica Acta 1997 1346 1 75 85 2-s2.0-0002840987 10.1016/S0005-2760(97)00021-0 (Pubitemid 27220312)
72. Frolov A., Cho T. H., Murphy E. J., Schroeder F., Isoforms of rat liver fatty acid binding protein differ in structure and affinity for fatty acids and fatty acyl CoAs. Biochemistry 1997 36 21 6545 6555 2-s2.0-0031008197 10.1021/bi970205t (Pubitemid 27231413)
73. He Y., Yang X., Wang H., Estephan R., Francis F., Kodukula S., Storch J., Stark R. E., Solution-state molecular structure of apo and oleate-liganded liver fatty acid-binding protein. Biochemistry 2007 46 44 12543 12556 2-s2.0-35848954991 10.1021/bi701092r (Pubitemid 350060081)
74. 13C NMR study. The Journal of Biological Chemistry 1989 264 5 2700 2710 2-s2.0-0024595766 (Pubitemid 19057762)
75. 13C NMR studies of fatty acid-protein interactions: comparison of homologous fatty acid-binding proteins produced in the intestinal epithelium. Molecular and Cellular Biochemistry 1990 98 1-2 101 110 2-s2.0-0025196603 (Pubitemid 20309221)
76. Cistola D. P., Walsh M. T., Corey R. P., Hamilton J. A., Brecher P., Erratum:interactions of oleic acid with liver fatty acid binding protein: a carbon-13 NMR study, 28(8):3628, 1989. Biochemistry 1988 27 2 711 717 2-s2.0-33845184210 (Pubitemid 18043516)
77. Fukai F., Kase T., Shidotani T., Nagai T., Katayama T., Multiple classes of binding sites for palmitic acid on the fatty acid-binding protein molecule. Biochemistry International 1989 18 6 1101 1105 2-s2.0-0024344454 (Pubitemid 19166387)
78. Long D., Yang D., Buffer interference with protein dynamics: a case study on human liver fatty acid binding protein. Biophysical Journal 2009 96 4 1482 1488 2-s2.0-62649119790 10.1016/j.bpj.2008.10.049
79. Thompson J., Winter N., Terwey D., Bratt J., Banaszak L., The crystal structure of the liver fatty acid-binding protein. A complex with two bound oleates. The Journal of Biological Chemistry 1997 272 11 7140 7150 2-s2.0-0030986132 10.1074/jbc.272.11.7140 (Pubitemid 27166420)
80. Jolly C. A., Hubbell T., Behnke W. D., Schroeder F., Fatty acid binding protein: stimulation of microsomal phosphatidic acid formation. Archives of Biochemistry and Biophysics 1997 341 1 112 121 2-s2.0-0031148623 10.1006/abbi.1997.9957 (Pubitemid 27198038)
81. Jolly C. A., Murphy E. J., Schroeder F., Differential influence of rat liver fatty acid binding protein isoforms on phospholipid fatty acid composition: phosphatidic acid biosynthesis and phospholipid fatty acid remodeling. Biochimica et Biophysica Acta 1998 1390 3 258 268 2-s2.0-0032559645 10.1016/S0005-2760(97)00186-0 (Pubitemid 28135287)
82. Maatman R. G. H. J., van Moerkerk H. T. B., Nooren I. M. A., van Zoelen E. J. J., Veerkamp J. H., Expression of human liver fatty acid-binding protein in Escherichia coli and comparative analysis of its binding characteristics with muscle fatty acid-binding protein. Biochimica et Biophysica Acta 1994 1214 1 1 10 2-s2.0-0028136965 10.1016/0005-2760(94)90002-7 (Pubitemid 24269115)
83. Hostetler H. A., Balanarasimha M., Huang H., Kelzer M. S., Kaliappan A., Kier A. B., Schroeder F., Glucose regulates fatty acid binding protein interaction with lipids and PPAR α Journal of Lipid Research 2010 51 11 3103 3116 2-s2.0-78149335209 10.1194/jlr.M005041
84. Sharma A., Sharma A., Fatty acid induced remodeling within the human liver fatty acid binding protein. The Journal of Biological Chemistry 2011 286 36 31924 31928 10.1074/jbc.M111.270165
85. Malapaka R. R. V., Khoo S. K., Zhang J., Choi J. H., Zhou X. E., Xu Y., Gong Y., Li J., Chalmers M. J., Chang L., Resau A. J.H., Griffin P. R., Chen Y. E., Xu H. E., Identification and mechanism of 10-carbon fatty acid as modulating ligand of peroxisome proliferator activated receptors. The Journal of Biological Chemistry 2012 287 1 181 195
86. Xu H. E., Lambert M. H., Parks V. G., Parks D. J., Blanchard S. G., Brown P. J., Sternbach D. D., Lehmann J. M., Wisely G. B., Willson T. M., Kliewer S. A., Milburn M. V., Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Molecular Cell 1999 3 3 397 406 2-s2.0-0033105510 10.1016/S1097-2765(00)80467-0 (Pubitemid 29290680)
87. Lane M. D., Hu Z., Cha S.-H., Dai Y., Wolfgang M., Sidhaye A., Role of malonyl-CoA in the hypothalamic control of food intake and energy expenditure. Biochemical Society Transactions 2005 33 5 1063 1067 2-s2.0-27844568239 10.1042/BST20051063 (Pubitemid 41659114)
88. Schmidt A., Vogel R., Holloway M. K., Rutledge S. J., Friedman O., Yang Z., Rodan G. A., Friedman E., Transcription control and neuronal differentiation by agents that activate the LXR nuclear receptor family. Molecular and Cellular Endocrinology 1999 155 1-2 51 60 2-s2.0-0032821271 10.1016/S0303-7207(99)00115- X (Pubitemid 29460964)
89. Karam W. G., Ghanayem B. I., Induction of replicative DNA synthesis and PPAR α -dependent gene transcription by Wy-14 643 in primary rat hepatocyte and non-parenchymal cell co-cultures. Carcinogenesis 1997 18 11 2077 2083 2-s2.0-0031409897 10.1093/carcin/18.11.2077 (Pubitemid 28134732)
90. Moya M., Gómez-Lechón M. J., Castell J. V., Jover R., Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile. Chemico-Biological Interactions 2010 184 3 376 387 2-s2.0-77949916811 10.1016/j.cbi.2010.01.008
91. Pawar A., Botolin D., Mangelsdorf D. J., Jump D. B., The role of liver X receptor- α in the fatty acid regulation of hepatic gene expression. The Journal of Biological Chemistry 2003 278 42 40736 40743 2-s2.0-0142103471 10.1074/jbc.M307973200 (Pubitemid 37280889)
92. Pawar A., Jump D. B., Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor α activity in rat primary hepatoctes. The Journal of Biological Chemistry 2003 278 38 35931 35939 2-s2.0-0141592581 10.1074/jbc.M306238200 (Pubitemid 37139911)
93. Rakhshandehroo M., Hooiveld G., Müller M., Kersten S., Comparative analysis of gene regulation by the transcription factor PPAR α between mouse and human. PLoS ONE 2009 4 8 2-s2.0-69449086702 10.1371/journal.pone. 0006796 e6796
94. Resseguie M., Song J., Niculescu M. D., da Costa K.-A., Randall T. A., Zeisel S. H., Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes. The FASEB Journal 2007 21 10 2622 2632 2-s2.0-34547782307 10.1096/fj.07-8227com (Pubitemid 47230690)
95. Richert L., Lamboley C., Viollon-Abadie C., Grass P., Hartmann N., Laurent S., Heyd B., Mantion G., Chibout S. D., Staedtler F., Effects of clofibric acid on mRNA expression profiles in primary cultures of rat, mouse and human hepatocytes. Toxicology and Applied Pharmacology 2003 191 2 130 146 2-s2.0-0042734963 10.1016/S0041-008X(03)00231-X (Pubitemid 36999849)
96. Wang Y., Torres-Gonzalez M., Tripathy S., Botolin D., Christian B., Jump D. B., Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition. Journal of Lipid Research 2008 49 7 1538 1552 2-s2.0-50949112066 10.1194/jlr.M800123-JLR200
97. Xu J., Christian B., Jump D. B., Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor- α agonist. The Journal of Biological Chemistry 2006 281 27 18351 18362 2-s2.0-33745856925 10.1074/jbc.M601277200 (Pubitemid 44035492)
98. Hostetler H. A., Huang H., Kier A. B., Schroeder F., Glucose directly links to lipid metabolism through high affinity interaction with peroxisome proliferator-activated receptor α The Journal of Biological Chemistry 2008 283 4 2246 2254 2-s2.0-38349159588 10.1074/jbc.M705138200
99. Cline G. W., Petersen K. F., Krssak M., Shen J., Hundal R. S., Trajanoski Z., Inzucchi S., Dresner A., Rothman D. L., Shulman G. I., Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. The New England Journal of Medicine 1999 341 4 240 246 2-s2.0-0033595120 10.1056/NEJM199907223410404 (Pubitemid 29334522)
100. John S. A., Ottolia M., Weiss J. N., Ribalet B., Dynamic modulation of intracellular glucose imaged in single cells using a FRET-based glucose nanosensor. Pflügers Archiv 2008 456 2 307 322 2-s2.0-42049114503 10.1007/s00424-007-0395-z
101. Harris R. A., Devlin T. M., Carbohydrate metabolism I: major metabolic pathways and their control. Textbook of Biochemistry with Clinical Correlations 2006 Hoboken, NJ, USA John Wiley and Sons 581 635
102. Garrett R. H., Grisham C. M., Garrett R. H., Grisham C. M., Glycolysis. Biochemistry 2010 Boston, Mass, USA Brooks Cole 535 562
103. Williamson D. H., Brosnan J. T., Bergmeyer H. U., Concentrations of metabolites in animal tissues. Methods of Enzymatic Analysis 1974 4 New York, NY, USA Academic Press 2266 2302
104. Murphy E. J., Edmondson R. D., Russell D. H., Colles S., Schroeder F., Isolation and characterization of two distinct forms of liver fatty acid binding protein from the rat. Biochimica et Biophysica Acta 1999 1436 3 413 425 2-s2.0-0033521690 10.1016/S0005-2760(98)00150-7 (Pubitemid 29242922)
105. Schroeder F., Jolly C. A., Cho T. H., Frolov A., Fatty acid binding protein isoforms: structure and function. Chemistry and Physics of Lipids 1998 92 1 1 25 2-s2.0-0031835111 10.1016/S0009-3084(98)00003-6 (Pubitemid 28236431)
106. Diradourian C., Girard J., Pégorier J.-P., Phosphorylation of PPARs: from molecular characterization to physiological relevance. Biochimie 2005 87 1 33 38 2-s2.0-14544272384 10.1016/j.biochi.2004.11.010 (Pubitemid 40298763)
107. Shalev A., Siegrist-Kaiser C. A., Yen P. M., Wahli W., Burger A. G., Chin W. W., Meier C. A., The peroxisome proliferator-activated receptor α is a phosphoprotein: regulation by insulin. Endocrinology 1996 137 10 4499 4502 2-s2.0-0029784760 10.1210/en.137.10.4499 (Pubitemid 26321901)
108. Pourcet B., Pineda-Torra I., Derudas B., Staels B., Glineur C., SUMOylation of human peroxisome proliferator-activated receptor α inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR. The Journal of Biological Chemistry 2010 285 9 5983 5992 2-s2.0-77949878458 10.1074/jbc.M109.078311
109. Berrone E., Beltramo E., Solimine C., Ape A. U., Porta M., Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. The Journal of Biological Chemistry 2006 281 14 9307 9313 2-s2.0-33646938091 10.1074/jbc.M600418200 (Pubitemid 43864646)
110. Hostetler H. A., Syler L. R., Hall L. N., Zhu G., Schroeder F., Kier A. B., A novel high-throughput screening assay for putative antidiabetic agents through PPAR α interactions. Journal of Biomolecular Screening 2008 13 9 855 861 2-s2.0-53649088608 10.1177/1087057108323127
111. Stewart J. M., Dewling V. F., Wright T. G., Fatty acid binding to rat liver fatty acid-binding protein is modulated by early glycolytic intermediates. Biochimica et Biophysica Acta 1998 1391 1 1 6 2-s2.0-0032489491 10.1016/S0005-2760(97)00202-6 (Pubitemid 28143969)
112. Parks E. J., Skokan L. E., Timlin M. T., Dingfelder C. S., Dietary sugars stimulate fatty acid synthesis in adults. Journal of Nutrition 2008 138 6 1039 1046 2-s2.0-44449096155 (Pubitemid 351769126)
113. Wei Y., Wang D., Topczewski F., Pagliassotti M. J., Fructose-mediated stress signaling in the liver: implications for hepatic insulin resistance. Journal of Nutritional Biochemistry 2007 18 1 1 9 2-s2.0-37849188713 10.1016/j.jnutbio.2006.03.013 (Pubitemid 44827722)
114. Robins S. J., Fibrates and coronary heart disease reduction in diabetes. Current Opinion in Endocrinology and Diabetes 2002 9 4 312 322 2-s2.0-0036705773 10.1097/00060793-200208000-00004 (Pubitemid 36092160)